{"text":"Compound was tested for plasma inhibition of Angiotensin I converting enzyme activity in the conscious rat. Expressed as Inhibition of AI pressor response at 6 hr at a dose of 12.1 mg\/kg po","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antagonist activity of compound against Beta-1 adrenergic receptor in isolated guinea pig left atria","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Minimum protective concentration against beta-lactamase in Staphylococcus aureus (95 strain)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of aromatase activity in human placental microsomes determined by radiometric assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"pKi value for Dopamine receptor D2 binding site","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity measured in CHO cells stably transfected with the human endothelin B receptor","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Concentration required to displace 50% of a radiolabeled farnesyltransferase inhibitor from FPTase in cultured Ha-Ras transformed RAT1 cells","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"In vitro inhibitory activity against HMG CoA reductase","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiviral activity against herpes simplex virus type I was measured at 5 uM concentration.","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibition of human histone deacetylase (mixture of HDAC1 and HDAC2) prepared from K562 erythroleukemia cells.","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxic activity against human neuroblastoma IMR32 cells which over-express somatostatin receptors; na is not active","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Concentration inhibiting radiolabeled spermidine transport in L1210 cells.","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of glycogen synthesis in rat skeletal muscle L6 cells (inactive)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Nephrotoxicity upon intragastric administration was assessed in mice kidney as proximal tublar necrosis deep in the cortex at a dose of 10 mM","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity against HIV-Protease was determined","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"The compound was tested for its binding affinity to Poly (dA-dT) by using ethidium displacement assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Ability to displace ethidium bromide from double stranded synthetic Poly (dA-dT); ND = no data","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Tested for binding association constant against Poly (dG-dC) using ethidium bromide assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]PDBu from protein kinase C beta C1b domain","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Dissociation constant against stem loop IIB region of RRE-response element RNA was reported","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Opioid agonist activity by measuring the analgesia produced after 10 mg\/kg administration in rats; none","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Amount of milk ingested after the 120 min methamphetamine-challenges, produced by the compound at 0.312 mg\/kg in fasted rats","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Percent decrease in angiotensin I pressor response was measured in rat, administered intravenously at dose 0.010 mg\/kg","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of 3[H]9-cis-retinoic acid binding to Retinoic acid receptor RXR-alpha expressed in CV-1 cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibitory activity against type-1 human steroid 5-alpha-reductase at a concentration of 2.5 uM","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"The compound was tested for relative binding affinity against calf uterine receptor using [3H]estradiol as radioligand","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"5-HTP accumulation in limbic system was determined in vivo","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Compound was evaluated for the binding constant for association with nicotinic acetylcholine receptor (nAChR)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against methicillin-resistant Staphylococcus aureus B42876","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Displacement of 3H]RX821002 from rat cortex adrenergic alpha-2 receptor","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]SR141716A from human CB1 receptor expressed in CHO cells at 10 uM","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiviral activity against hepatitis C virus","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to human ERbeta","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antagonist activity at human MR ligand binding domain expressed in african green monkey COS7 cells in presence of aldosterone by Gal4 hybrid assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Anxiolytic-like activity in ddY mouse assessed as ambulatory activity at 1 mg\/kg, po for 7 days measured 24 hrs after final drug administration assessed per 5 mins by tilting type ambulometer test","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiparasitic activity against Toxoplasma gondii infected in HFF cells at 1 uM after 24 hrs by [3H]uracil incorporation assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to single stranded AT-rich oligonucleotide assessed as retardation of oligonucleotide movement by agarose gel electrophoresis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Antifungal activity against Candida tropicalis isolate 0022-021 after 24 hrs by CLSI M27-A2 broth microdilution method in presence of RPMI 1640 medium","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Stabilization of human G4-KIT2 DNA quadruplex assessed as melting temperature by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to G-quadruplex F21T DNA assessed as change in melting temperature at 3 uM under Na+ ionic conditions by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to G-quadruplex F21T DNA assessed as quadruplex stabilization at 3 uM by FRET assay in presence of duplex ds26 oligonucleotide","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to bone assessed as drug level bound to cattle bone meal powder by fluorescence assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to poly(dA).poly(dT) DNA assessed as change in melting temperature","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA at 80 uM by spectrophotometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human MCF7 cells by SRB assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA in sodium cacodylate buffer assessed as melting temperature at compound\/DNA ratio 0.3 at pH 7","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H] 2-((1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)-5-(2-methyloctan-2-yl)phenol from human CB2 receptor expressed CHO-K1 cells by liquid scintillation counting","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of 4-methylumbelliferydiacetyl-chitobiose from Serratia marcescens ChiB","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding constant for PIM1 kinase domain","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to Escherichia coli pUC19 DNA assessed as form 1 DNA level at 0.130 mM after 8.08 hrs by agarose gel electrophoresis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of radioligand binding to human adrenergic Alpha-2C receptor at 10 uM after 60 mins","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of Torpedo california AChE at 25 uM by Ellman's method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of 26S proteasome beta 2 in human HEK293 cell lysate assessed as residual activity at 0.03 uM after 1 hr","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of SRPK1 at 3 to 6 uM relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of cKIT","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antilipolytic activity in po dosed rat assessed as reduction plasma free fatty acids levels","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiproliferative activity against human CCRF-CEM cells at 10 uM assessed as cell growth inhibition relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimicrobial activity against Beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae with Ile449Val, Asn526Lys substitutions in penicillin-binding protein 3 by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Agonist activity at muscarinic M4 receptor in wild type mouse hippocampal CA1 pyramidal neuron assessed as increase in carbachol-induced reduction in excitatory postsynaptic current at 5 uM by whole-cell electrophysiology relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to (CAG-CAG) trinucleotide repeats at 120 uM by ESI-TOF mass spectroscopy","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human recombinant GABAA receptor","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cell cycle arrest in human U2OS cells overexpressing human KRAS2 assessed as accumulation at G1 phase at 15 nM after 48 hrs by CMV-GFP reporter assay method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of MBOAT5 mediated Wnt3a pathway activity in mouse L cell expressing Wnt3a assessed as decreased firefly luciferase reporter expression at 0.25 uM to 1 uM","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against Salmonella enterica serovar Enteritidis assessed as percent susceptible isolates by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antimicrobial activity against Enterococcus faecalis ATCC 29212 by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antibacterial activity against 1 x 10'4 CFU Streptococcus pneumoniae ATCC 6305 after 18 hrs by CLSI 2-fold agar dilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Effect on glutathione peroxidase expression in human A549 cells assessed as transcript level at 662 nM after 24 hrs by RT-qPCR analysis relative to untreated control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]AVP from human V2 receptor expressed in CHO cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to SAM1 riboswitch aptamer assessed as change in heat at 0.5 mM at pH 7.5 by Isothermal titration calorimetry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to supercoiled pRYG DNA at 0.1 uM after 10 mins by by agarose gel electrophoresis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]Iloprost from human prostanoid IP receptor expressed in CHO cells after 60 mins by liquid scintillation counting","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human telomeric AGGG(TTAGGG)3 quadruplex in second binding event at 480 to 640 uM every 300 to 400 secs at pH 7 by isothermal titration calorimetry method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to duplex DNA d(CGCGAATTCGCG)2 duplex at pH 7 by isothermal titration calorimetry method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to DNA assessed as increase in hypochromicity by UV-spectroscopic analysis with compound pretreatment with CYP450","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of basal activity of human histamine H3 receptor expressed in CHO cells assessed as inhibition of RAHM-induced [35S]GTPgammaS binding after 4 hrs by beta liquid scintillation counting","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of A73U tRNA(Tyr)-5'Rhd-AM1A T box antiterminator RNA complex assessed as reduction in anisotrophy changes by at 100 uM by fluorescence anisotropy-based assay relative to untreated control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Cell cycle arrest in human SK-BR-3 cells assessed as accumulation at G2\/M phase at 0.25 uM after 18 hrs using propidium iodide staining by FACS analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as hypochromicity at 1 x 10'-5 M by UV-Vis spectroscopy","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as melting temperature at 5 x 10'-6 M by thermal denaturation assay (Rvb = 68.4 degC)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to 5'-AGCGCT-3' sequence in 125 bp 5'-[32P]-radiolabeled DNA at 100 uM after 30 mins by DNase1 footprinting analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to chicken blood dsDNA assessed as decrease in current at 1 x 10 '-3 M at pH 7.4 by cyclic voltammetry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of N-terminal 6-histine tagged Bacillus anthracis LF 263-C terminal catalytic domain using MCA-KKVYPYPME-Dap(Dnp)-NH2 as substrate after 4 hrs by FRET analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA in citrate-phosphate buffer at pH 7 assessed as change in viscosity by hydrodynamic method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human recombinant 5HT2C receptor","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Anticonvulsant activity in mouse assessed as protection against subcutaneous pentylenetetrazole-induced seizures at 300 mg\/kg, ip after 4 hrs","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antifungal activity against Aspergillus fumigatus ATCC 26934 by NCCLS broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Growth inhibition of human MDA-MB-231 cells after 72 hrs by celltiter-blue viability assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Agonist activity at rat mGlu8R expressed in HEK293 cells co-expressing GIRK channels by thallium flux assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of mTORC1 in human PC3 cells xenografted mouse assessed as reduction of phosphorylated p70S6K level at 25 to 100 mg\/kg, po after 6 hrs","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Anticoagulant activity in Rattus norvegicus Wistar (rat) diabetic-hyperlipidemic model assessed as decrease in TFa activity in aorta measuring clotting time at 10.91% administered through feeding measured after 12 weeks (Rvb = 36.25 +\/- 1.39 secs)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Hypolipidemic activity in high cholesterol diet fed Mus musculus KM (mouse) assessed as low density lipoprotein cholesterol at 150 mg\/kg, ig for 10 days (Rvb = 4.2972 +\/- 1.1725 mmol\/l)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Bactericidal activity against Salmonella typhi after 72 hrs by serial subcultivation method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to human full-length His-tagged Myt1 kinase expressed in HEK293 cells at 5 uM by TR-FRET based binding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to PPARgamma (unknown origin) at 10 uM by Polarscreen competitor assay relative to rosiglitazone","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antifungal activity against Saccharomyces cerevisiae MTCC 36 at 50 ug\/ml after 48 hrs by agar well diffusion method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to calf thymus DNA assessed as intercalation after 2 hrs by Stern-Volmer plot relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as hypochromicity at 20 uM after 2 hrs by UV-Vis absorption titration analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as intercalation after 2 hrs by UV-Vis absorption titration analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to N-terminal domain of human Hsp90alpha by FAXS competitive binding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]N-alpha-methylhistamine from rhesus monkey histamine H3 receptor expressed in CHO cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mouse assessed as reduction of parasitemia at 10 mg\/kg, po qd administered 3 days by flow cytometric analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Growth inhibition of human OVCAR8 cells after 48 hrs by sulforhodamine B assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human TGFbetaR2 (amino acid residues M1 to D159) at 0.125 to 2 uM by surface plasmon resonance assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to M4 receptor (unknown origin) by PDSP assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Growth inhibition of human MDA-MB-231 cells assessed as cell growth at 10'-5 M after 48 hrs by sulforhodamine B assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human A549 cells assessed as necrotic cells at 5 uM after 48 hrs by annexin V\/PI staining-based FACS analysis (Rvb = 2.8 %)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of bovine plasma factor 10a using CH3OCO-D-CHA-Gly-Arg-pNA.AcoH substrate at 5 uM","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Stimulation of growth in human MCF7 cells at 0.1 to 20 uM after 4 days by MTT assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimicrobial activity against Bacillus subtilis ATCC 6633 assessed as inhibition of microbial growth incubated for 24 hrs by broth dilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Cytotoxicity against human A673 cells after 96 hrs by MTS assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human HepG2 cells assessed as viable cells at 20 uM after 6 hrs by annexin V\/propidium iodide staining-based flow cytometric analysis (Rvb = 90.9%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to RPA70N protein (unknown origin) by HSQC NMR-based titration method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of PU-FITC3 from recombinant TRAP-1 (unknown origin) after 24 hrs by fluorescence polarization assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to KAT2A in human HUT78 cells incubated for 45 mins by mass spectrometry based bromosphere chemoproteomic assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to NTSR1 in human HT-29 cells after 2 hrs by liquid scintillation counting","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of PDK1 (unknown origin) by FRET-based Z-lyte assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]NVP-QAW039 from human DP2 receptor expressed in CHO cell membranes assessed as association rate constant by TopCount scintillation assay","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antitumor activity against mouse H22 cells implanted in Kunming mouse assessed as tumor growth inhibition at 24 mg\/kg, ip administered once in every 3 days totally for 3 times relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against Bacillus subtilis NBRC 13719 after overnight incubation by microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antibacterial activity against Escherichia coli MTCC 443 after 24 hrs by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antagonist activity at muscarinic M1 receptor (unknown origin)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to HAX1 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]BRL 43694 from human recombinant 5-HT3 receptor at 10 uM after 120 mins by scintillation counting analysis relative to control","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human HCC827 cells assessed as increase in hypodiploid DNA content at 50 to 100 nM after 72 hrs by propidium iodide staining flow cytometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antifungal activity against Candida albicans ATCC 90028 assessed as inhibition of metabolic activity at 10 ug\/ml after 48 hrs in presence of 80 ug\/ml fluconazol by XTT assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Ratio of Kinact to Ki for recombinant His6-tagged PAD1 (unknown origin) preincubated for 10 mins followed by BAEE substrate addition measured after 15 mins by COLDER assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of recombinant human full length N-terminal His6-tagged and N-terminal GST-tagged CDK5\/p35 expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human full length ERK2 (M1 to S360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human full length PHKG1 (M1 to Y387 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length ULK2 (M1 to S301 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of recombinant GST-tagged human PDE9A2 expressed in insect cells using cGMP as substrate after 1 hr by IMAP TR-FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to partial length human PAK2 (P151 to R525 residues) expressed in bacterial expression system by KINOMEscan assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Potency index, ratio of cefaclor MIC to compound MIC for methicillin-resistant Staphylococcus aureus NRS70","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Protac activity against VHL\/MEK1 in human SK-MEL-28 cells harboring with BRAF V600E variant assessed as degradation of MEK1 at 0.1 to 0.3 uM after 4 hrs by Western blot analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against carbapenem-resistant Escherichia coli BAA-2469 clinical isolates after 18 to 20 hrs in aerobic condition by CLSI-based broth microdilution assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibition of class 1 HDAC in human Cal27CisR cells assessed as potentiation of cisplatin-induced apoptosis by measuring increase in accumulation at sub-G1 phase at 5 uM preincubated for 48 hrs followed by cisplatin addition and measured after 24 hrs by propidium iodide staining based flow cytometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiinflammatory activity in Wistar albino rat assessed as reduction in carrageenan-induced paw volume at 12.5 mg\/kg, ip measured after 1 hr by plethysmometric method (Rvb = 1.43 +\/- 0.19 ml)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human A549 cells assessed as early apoptotic cells at 2.5 uM after 12 hrs by Annexin V-FITC\/propidium iodide staining-based flow cytometric analysis (Rvb = 7.19%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to ABL2 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of ALK in mouse NIH-3T3 cells","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length autoinhibited FLT3 (H564 to Y969 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length SBK1 (P23 to P348 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human full length SRPK1 (M1 to S655 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of YqiG protein expression in Bacillus subtilis 168 at 2.3 uM incubated for 15 mins by 35S-methionine pulse labeling based 2D-PAGE analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to HIV1 cYTA48P envelope glycoprotein gp120 infected in human TZM-b1 cells assessed as induction of conformational changes by measuring combination index at 450:1 ratio of test compound to KD-247 measured after 48 hrs","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus duplex DNA assessed as induction of hyperchromic shift at 257 nanometer at 50 uM in pH 7 phosphate buffer by UV-vis spectrophotometric analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to BLM in human HCT116 cells cotransfected with DSB model and I-SceI plasmid assessed as reduction in recruitment of protein to DSB site in DNA at 1 uM measured after 24 hrs by chromatin immunoprecipitation assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Activation of human FXR LBD expressed in HEK293T cells assessed as induction of receptor activation at 30 uM incubated for 12 to 14 hrs by luciferase reporter gene assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to DNA (unknown origin) at 0.1 to 0.2 mM by agarose gel electrophoresis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of EtBr from calf thymus DNA assessed per base pair incubated for 3 mins by fluorescence based assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as change in melting temperature at DNA to ligand ratio at 40:1 by spectrophotometric method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as hyperchromic shift measured at 362 nm at 3*10^-5 mol\/L by double beam UV-Vis spectroscopic analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity at Escherichia coli pBR322 DNA assessed as unwinding of supercoiled DNA at 10 uM incubated for 10 mins in presence of human topoisomerase 1 by agarose gel based electrophoresis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Induction of ROS-mediated apoptosis in human SGC-7901 cells assessed as early apoptotic cells at 1 uM incubated for 48 hrs by annexin V-PE and 7-AAD staining based flow cytometry analysis (Rvb = 1.89 %)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiviral activity against HCV J6\/JFH\/JC1 harboring D168V mutant infected in human Huh7.5 cells assessed as inhibition of viral replication measured after 72 hrs by qRT-PCR analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Induction of apoptosis in human HCC827 cells assessed as early apoptotic cells at 1 uM measured after 24 hrs by Annexin V-FITC\/propidium iodide staining based flow cytometry (Rvb = 2.49%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of recombinant human His6\/SUMO-tagged HDAC8 expressed in Escherichia coli (BL21) DE3 pLysS using Boc-Lys(trifluoroacetyl)-AMC as substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by fluorescence assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Gastroprokinetic activity in CD-1 mouse assessed as stimulation of gastrointestinal motility by measuring fecal number at 10 mg\/kg, po measured after 2 hrs (Rvb = 5.3 +\/-0.7 No_unit)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human MAP3K2 at 1 uM by KINOMEscan scanMAX assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antitumour activity against human LNCaP cells xenografted in CB17 SCID mouse assessed as tumour growth inhibition at 2.5 mg\/kg, IT(Intratumoral) administered once in every week for 25 days","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of sphingosine D-erythro [3-3H] I- phosphate from human S1P2 receptor expressed in CHO cell membrane","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to FGFR4 (unknown origin) assessed as dissociation constant by competition binding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Reactivation of NIMP-inhibited recombinant His-TEV-tagged human AChE expressed in CHO-K1 cells assessed as reactivation constant, Kr by measuring thiophenol levels by UV-vis absorption spectroscopy","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antagonist activity at ERbeta (unknown origin) assessed as inhibition of fluorescein-labelled coactivator PGC1 peptide recruitment at 34 nM incubated for 30 mins by LanthaScreen TR-FRET assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human HT-29 cells incubated for 72 hrs by MTT assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of ABCG2 (unknown origin) expressed in dog MDCK-II-BCRP cells assessed as Hoechst 33342 accumulation using Hoechst 33342 as substrate by microplate reader analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Agonist activity at human RXR-alpha expressed in U2OS cells assessed as maximum relative efficacy at 100 uM by PathHunter assay relative to 9-cis-retinoic acid","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to TCP-stimulated NMDA (unknown origin)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human G-quadruplex telomeric DNA F21T (5'-duplex FAM-GGGTTAGGGTTAGGGTTAGGG-TAM-3') assessed as stabilization by measuring change in melting temperature at 5 uM by FRET melting assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
